NIH-led effort launches Big Data portal for Alzheimer’s drug discovery

Innovative collaboration, rapid data-sharing opens research to wider community.

A National Institutes of Health-led public-private partnership to transform and accelerate drug development achieved a significant milestone today with the launch of a new Alzheimer’s Big Data portal — including delivery of the first wave of data — for use by the research community. The new data sharing and analysis resource is part of the Accelerating Medicines Partnership (AMP), an unprecedented venture bringing together NIH, the U.S. Food and Drug Administration, industry and academic scientists from a variety of disciplines to translate knowledge faster and more successfully into new therapies.

Read more View All News

This page was last updated on Friday, January 21, 2022